Highlights Torrent Pharmaceuticals Limited

Stocks

TORNTPHARM

INE685A01028

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 03:58:22 13/07/2026 pm IST			5-day change	1st Jan Change
4,948.05 ^INR	+0.91%		+3.83%	+28.80%

09/07	India's Dr Reddy's says semaglutide shipping disruption to last until at least late October	RE
09/07	India's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice	RE

Highlights

09/07	Torrent Pharmaceuticals Limited Implements Voluntary Recall for Select Batches of Semalix Injection Disposable Pens	CI
23/06	Torrent Pharmaceuticals Limited Approves Final Dividend for the Financial Year Ended 31 March, 2026	CI
22/05	Torrent Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
22/05	Indian drugmaker Torrent Pharma posts lower quarterly profit on acquisition costs	RE
22/05	Torrent Pharmaceuticals Limited Recommends Final Dividend, Payable on or Around 25 June 2026	CI
06/05	Algorae Pharmaceuticals executes license & supply agreement with Torrent Pharma	RE
21/03	Torrent Pharmaceuticals Limited Launches Oral and Injectable Formulations of Semaglutide	CI
13/02	Torrent Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
13/02	Torrent Pharma Q3 consol net profit 6.35 billion rupees	RE
13/02	Torrent Pharmaceuticals Limited Announces Interim Dividend, Payable on or Around 6 March, 2026	CI
23/01	Torrent Pharma buys 2.36% stake of J.B. Chemicals	RE
21/01	Torrent Pharma completes acquisition of JB Chemicals shares	RE
19/01	India new issue-Torrent Pharma completes largest acquisition-funding debt this fiscal year, bankers say	RE
14/01	India new issue-Torrent Pharma to sell largest acquisition-funding debt this FY, bankers say	RE
07/11	India's Torrent Pharma posts profit boost on strong demand for chronic illness drugs	RE
07/11	Torrent Pharma Q2 consol net profit 5.91 billion rupees	RE
07/11	Torrent Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
07/11	Eisai Settles U.S. Patent Litigation Over Lenvatinib With Torrent Pharmaceuticals	MT
21/25/21	India competition regulator approves acquisition of J.B. Chemicals & Pharmaceuticals by Torrent Pharma	RE
30/25/30	Torrent Pharmaceuticals - Demand notice imposes penalty of 6 million rupees	RE
25/25/25	SA's Competition Commission approves proposed Torrent Pharmaceuticals/ JB Pharma deal, with conditions	RE
24/25/24	Torrent Pharma Secures South African Antitrust Approval for J.B. Chemicals Deal	MT
23/25/23	Torrent Pharmaceuticals to buy controlling stake in J. B. Chemicals	RE
29/25/29	Torrent Pharmaceuticals' Fiscal Q1 Consolidated Profit Rises; EPS Misses Estimates	MT
28/25/28	Torrent Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI